Sophie Leducq
3
Documents
Identifiants chercheurs
- sophie-leducq
- IdRef : 238720330
- 0000-0002-4860-6365
Présentation
Publications
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimusBritish Journal of Dermatology, 2023, 188 (1), pp.152-154. ⟨10.1093/bjd/ljac028⟩
Article dans une revue
hal-04233650v1
|
|
Research Techniques Made Simple: Randomized~Controlled Trials for Topical Drugs in~Dermatology: When~and How Should We Use a~Within-Person Design?Journal of Investigative Dermatology, 2020, 140 (5), pp.931-938.e1. ⟨10.1016/j.jid.2020.03.945⟩
Article dans une revue
hal-03159474v1
|
|
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase designTrials, 2018, 19 (1), pp.340. ⟨10.1186/s13063-018-2725-1⟩
Article dans une revue
hal-01913363v1
|